These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


446 related items for PubMed ID: 12213056

  • 21. Synthesis and in vitro and in vivo functional studies of ortho-substituted phenylpiperazine and N-substituted 4-N-(o-methoxyphenyl)aminopiperidine analogues of WAY100635.
    Mensonides-Harsema MM, Liao Y, Böttcher H, Bartoszyk GD, Greiner HE, Harting J, de Boer P, Wikström HV.
    J Med Chem; 2000 Feb 10; 43(3):432-9. PubMed ID: 10669570
    [Abstract] [Full Text] [Related]

  • 22. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R.
    J Med Chem; 2001 Dec 06; 44(25):4431-42. PubMed ID: 11728188
    [Abstract] [Full Text] [Related]

  • 23. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L, Mocaër E, Bertaglia A, Samanin R.
    Neuropharmacology; 2000 Apr 03; 39(6):1037-43. PubMed ID: 10727714
    [Abstract] [Full Text] [Related]

  • 24. 5-HT(1A) receptor agonist-antagonist binding affinity difference as a measure of intrinsic activity in recombinant and native tissue systems.
    Watson J, Collin L, Ho M, Riley G, Scott C, Selkirk JV, Price GW.
    Br J Pharmacol; 2000 Jul 03; 130(5):1108-14. PubMed ID: 10882396
    [Abstract] [Full Text] [Related]

  • 25. Activation of 5-HT(1A) autoreceptors enhances the inhibitory effect of galanin on hippocampal 5-HT release in vivo.
    Yoshitake T, Yoshitake S, Yamaguchi M, Ogren SO, Kehr J.
    Neuropharmacology; 2003 Feb 03; 44(2):206-13. PubMed ID: 12623219
    [Abstract] [Full Text] [Related]

  • 26. Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse.
    Knobelman DA, Hen R, Blendy JA, Lucki I.
    J Pharmacol Exp Ther; 2001 Sep 03; 298(3):1092-100. PubMed ID: 11504806
    [Abstract] [Full Text] [Related]

  • 27. Imipramine but not 5-HT(1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT(1A) and 5-HT(4) receptors.
    Zahorodna A, Tokarski K, Bijak M.
    Eur J Pharmacol; 2002 May 17; 443(1-3):51-7. PubMed ID: 12044792
    [Abstract] [Full Text] [Related]

  • 28. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
    Mannoury la Cour C, Boni C, Hanoun N, Lesch KP, Hamon M, Lanfumey L.
    J Neurosci; 2001 Mar 15; 21(6):2178-85. PubMed ID: 11245702
    [Abstract] [Full Text] [Related]

  • 29. Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
    Colpaert FC, Bruins Slot LA, Koek W, Dupuis DS.
    Behav Brain Res; 2000 Dec 20; 117(1-2):41-51. PubMed ID: 11099756
    [Abstract] [Full Text] [Related]

  • 30. Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): a novel multimodal compound for the treatment of major depressive disorder.
    Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB.
    J Med Chem; 2011 May 12; 54(9):3206-21. PubMed ID: 21486038
    [Abstract] [Full Text] [Related]

  • 31. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
    Newman-Tancredi A, Rivet J, Chaput C, Touzard M, Verrièle L, Millan MJ.
    Eur J Pharmacol; 1999 Nov 19; 384(2-3):111-21. PubMed ID: 10611431
    [Abstract] [Full Text] [Related]

  • 32. Short-term effects of 3,4-methylen-dioxy-metamphetamine (MDMA) on 5-HT(1A) receptors in the rat hippocampus.
    Giannaccini G, Betti L, Pirone A, Palego L, Fabiani O, Fabbrini L, Mascia G, Giusti L, Macchia M, Giusiani M, Martini C, Lucacchini A.
    Neurochem Int; 2007 Dec 19; 51(8):496-506. PubMed ID: 17602794
    [Abstract] [Full Text] [Related]

  • 33. Facilitation by 8-OH-DPAT of passive avoidance performance in rats after inactivation of 5-HT(1A) receptors.
    Otano A, García-Osta A, Ballaz S, Frechilla D, Del Río J.
    Br J Pharmacol; 1999 Dec 19; 128(8):1691-8. PubMed ID: 10588924
    [Abstract] [Full Text] [Related]

  • 34. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 19; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 35. On the bioactive conformation of NAN-190 (1) and MP3022 (2), 5-HT(1A) receptor antagonists.
    Paluchowska MH, Mokrosz MJ, Bojarski A, Wesołowska A, Borycz J, Charakchieva-Minol S, Chojnacka-Wójcik E.
    J Med Chem; 1999 Dec 02; 42(24):4952-60. PubMed ID: 10585205
    [Abstract] [Full Text] [Related]

  • 36. SB-649915, a novel, potent 5-HT1A and 5-HT1B autoreceptor antagonist and 5-HT re-uptake inhibitor in native tissue.
    Scott C, Soffin EM, Hill M, Atkinson PJ, Langmead CJ, Wren PB, Faedo S, Gordon LJ, Price GW, Bromidge S, Johnson CN, Hagan JJ, Watson J.
    Eur J Pharmacol; 2006 Apr 24; 536(1-2):54-61. PubMed ID: 16571351
    [Abstract] [Full Text] [Related]

  • 37. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study.
    Gobbi G, Murphy DL, Lesch K, Blier P.
    J Pharmacol Exp Ther; 2001 Mar 24; 296(3):987-95. PubMed ID: 11181933
    [Abstract] [Full Text] [Related]

  • 38. Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT(2A) receptors in adult rat brain.
    Moreau X, Jeanningros R, Mazzola-Pomietto P.
    Neuropsychopharmacology; 2001 Jun 24; 24(6):652-62. PubMed ID: 11331145
    [Abstract] [Full Text] [Related]

  • 39. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
    Orjales A, Mosquera R, Toledo A, Pumar MC, García N, Cortizo L, Labeaga L, Innerárity A.
    J Med Chem; 2003 Dec 04; 46(25):5512-32. PubMed ID: 14640559
    [Abstract] [Full Text] [Related]

  • 40. Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
    Gur E, Dremencov E, Lerer B, Newman ME.
    Eur J Pharmacol; 2001 Jan 05; 411(1-2):115-122. PubMed ID: 11137865
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.